Dynavax Technologies Corp (DVAX)
11.65
-0.11
(-0.94%)
USD |
NASDAQ |
May 08, 16:00
11.50
-0.15
(-1.29%)
After-Hours: 20:00
Dynavax Technologies Free Cash Flow (Quarterly): 12.04M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.04M |
| September 30, 2023 | 30.78M |
| June 30, 2023 | 27.30M |
| March 31, 2023 | 26.34M |
| December 31, 2022 | 33.36M |
| September 30, 2022 | 60.28M |
| June 30, 2022 | 13.74M |
| March 31, 2022 | -51.80M |
| December 31, 2021 | 117.46M |
| September 30, 2021 | 62.58M |
| June 30, 2021 | 109.72M |
| March 31, 2021 | 36.28M |
| December 31, 2020 | -16.51M |
| September 30, 2020 | -28.09M |
| June 30, 2020 | -22.51M |
| March 31, 2020 | -36.22M |
| December 31, 2019 | -24.84M |
| September 30, 2019 | -31.16M |
| June 30, 2019 | -43.86M |
| March 31, 2019 | -50.78M |
| December 31, 2018 | -34.98M |
| September 30, 2018 | -36.57M |
| June 30, 2018 | -34.67M |
| March 31, 2018 | -40.27M |
| December 31, 2017 | -18.04M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.26M |
| June 30, 2017 | -17.40M |
| March 31, 2017 | -25.48M |
| December 31, 2016 | -27.52M |
| September 30, 2016 | -29.81M |
| June 30, 2016 | -27.73M |
| March 31, 2016 | -29.74M |
| December 31, 2015 | -24.57M |
| September 30, 2015 | -25.58M |
| June 30, 2015 | -24.62M |
| March 31, 2015 | -24.76M |
| December 31, 2014 | -17.33M |
| September 30, 2014 | -23.38M |
| June 30, 2014 | -23.13M |
| March 31, 2014 | -11.57M |
| December 31, 2013 | -12.16M |
| September 30, 2013 | -12.74M |
| June 30, 2013 | -15.98M |
| March 31, 2013 | -19.42M |
| December 31, 2012 | -8.796M |
| September 30, 2012 | -12.67M |
| June 30, 2012 | -16.16M |
| March 31, 2012 | -9.113M |
| December 31, 2011 | -5.866M |
| September 30, 2011 | -12.85M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-51.80M
Minimum
Mar 2022
117.46M
Maximum
Dec 2021
14.47M
Average
13.74M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | 44.99M |
| Esperion Therapeutics Inc | -37.06M |
| Deciphera Pharmaceuticals Inc | -28.87M |
| Ligand Pharmaceuticals Inc | -42.68M |
| Pacira BioSciences Inc | 46.26M |